Skip to main content
Log in

Anti-topoisomerase I antibodies in systemic lupus erythematosus as a marker of severe nephritis

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The authors report nine patients with systemic lupus erythematosus associated with anti-topoisomerase I antibodies (ELISA test) without features of systemic sclerosis. These antibodies were correlated with the disease activity and might be a marker of the severity of the closely related to difusse proliferative glomerulonephritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Gussin HAE, Ignat GP, Varga J, Teodorescu M (2001) Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 44:376–383

    Article  PubMed  CAS  Google Scholar 

  2. Mukai M, Sagawa A, Atsumi T et al (1993) Three cases of anti-Scl-70 (topoisomerase I) antibody associated with central nervous system lupus without renal disorder. J Rheumatol 20:1594–1597

    PubMed  CAS  Google Scholar 

  3. Stojanov L, Satoh M, Dooley MA, Kuwana M, Jennette JC, Reeves WH (1995) Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma. Lupus 4:314–317

    Article  PubMed  CAS  Google Scholar 

  4. Watanabe T, Tsuchida T, Kanda N, Tamaki K (1997) Avascular necrosis of bone in systemic lupus erythematosus : the predictive role of precipitating autoantibodies. Scand J Rheumatol 26:184–187

    Article  PubMed  CAS  Google Scholar 

  5. Al Attia HM, D'Souza MS (2003) Antitopoisomerase I antibody in patients with systemic lupus erythematosus/sicca syndrome without a concomitant scleroderma: two case reports. Clin Rheumatol 22:70–72

    Article  PubMed  CAS  Google Scholar 

  6. Ignat GP, Rat A-C, Sychra JJ, Vo J, Varga J, Teodorescu M (2003) Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies. J Rheumatol 30:1761–1769

    PubMed  CAS  Google Scholar 

  7. Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C (2003) Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology 42:276–279

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamed A. Hamidou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamidou, M.A., Audrain, M.A., Masseau, A. et al. Anti-topoisomerase I antibodies in systemic lupus erythematosus as a marker of severe nephritis. Clin Rheumatol 25, 542–543 (2006). https://doi.org/10.1007/s10067-005-0061-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-005-0061-9

Keywords

Navigation